News FDA rejects Sunovion's nebulised COPD drug The US regulator has rejected Sunovion’s nebulised therapy for chronic obstructive pulmonary disease (COPD), leaving the company struggling to stay ahead of rivals.
News European regulators back Chiesi COPD triple therapy Chiesi takes on Seretide and other lung drugs with Trimbow.
News GSK’s Relvar Ellipta comes out on top in real world study Encouraging results will support growth of its next generation respiratory treatment
News Circassia gives up on allergy treatments after second trial ... UK biotech to focus on respiratory drugs after house dust mite therapy fails.
News AZ strikes COPD deal with Circassia, suffers setback with bl... FDA rejects blood potassium drug for second time.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
